GetTopicDetailResponse(id=ec5d10661385, topicName=cadonilimab, introduction=cadonilimab, content=cadonilimab康方生物, image=null, comments=1, allHits=798, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=4754896, adminEncryptionId=f63e4754896, adminName=俠膽醫(yī)心, createdBy=f63e4754896, createdName=俠膽醫(yī)心, createdAvatar=, createdTime=Sun Sep 10 11:17:33 CST 2023, time=2023-09-10, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=479919, tagList=[TagDto(tagId=479919, tagName=cadonilimab)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2275852, encodeId=1e9b22e5852b8, content=<a href='/topic/show?id=10dc3890e66' target=_blank style='color:#2F92EE;'>#吉西他濱#</a> <a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a> <a href='/topic/show?id=ec5d10661385' target=_blank style='color:#2F92EE;'>#cadonilimab#</a> <a href='/topic/show?id=ab6d1290e04a' target=_blank style='color:#2F92EE;'>#納米白蛋白紫杉醇#</a>, objectTitle=iScience：我國(guó)學(xué)者揭示Cadonilimab聯(lián)合吉西他濱+納米白蛋白紫杉醇一線治療晚期胰腺癌療效, objectType=article, longId=890062, objectId=e085890062a5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721617667041_92910.jpg, objectUrl=/article/show_article.do?id=e085890062a5, replyNumber=0, likeNumber=17, createdTime=2025-08-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e085890062a5, moduleTitle=iScience：我國(guó)學(xué)者揭示Cadonilimab聯(lián)合吉西他濱+納米白蛋白紫杉醇一線治療晚期胰腺癌療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e085890062a5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2156980, encodeId=f75721569801c, content=<a href='/topic/show?id=ec5d10661385' target=_blank style='color:#2F92EE;'>#cadonilimab#</a><a href='/topic/show?id=f0a94946ebd' target=_blank style='color:#2F92EE;'>#康方生物#</a>, objectTitle=Lung Cancer：雙免疫新藥卡度尼利二線治療NSCLC的臨床試驗(yàn)失敗（AK104-202研究）, objectType=article, longId=790963, objectId=7f86e9096395, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230910/1694307022900_4754896.png, objectUrl=/article/show_article.do?id=7f86e9096395, replyNumber=0, likeNumber=106, createdTime=2023-09-10, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7f86e9096395, moduleTitle=Lung Cancer：雙免疫新藥卡度尼利二線治療NSCLC的臨床試驗(yàn)失?。ˋK104-202研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f86e9096395)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
俠膽醫(yī)心
2023-09-10發(fā)表于上海
